Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemo-Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

NCT07720167 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT07720167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemo-Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 1, 2030
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer